|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2001-5-16
|
|
pubmed:abstractText |
Hormone replacement therapy (HRT) is typically avoided for women with a history of breast cancer because of concerns that estrogen will stimulate recurrence. In this study, we sought to evaluate the impact of HRT on recurrence and mortality after a diagnosis of breast cancer.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0027-8874
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
16
|
|
pubmed:volume |
93
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
754-62
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:11353785-Adult,
pubmed-meshheading:11353785-Aged,
pubmed-meshheading:11353785-Breast Neoplasms,
pubmed-meshheading:11353785-Case-Control Studies,
pubmed-meshheading:11353785-Female,
pubmed-meshheading:11353785-Hormone Replacement Therapy,
pubmed-meshheading:11353785-Humans,
pubmed-meshheading:11353785-Menopause,
pubmed-meshheading:11353785-Middle Aged,
pubmed-meshheading:11353785-Models, Statistical,
pubmed-meshheading:11353785-Recurrence,
pubmed-meshheading:11353785-Risk
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
|
|
pubmed:affiliation |
Fred Hutchinson Cancer Research Center and Department of Epidemiology, University of Washington, Seattle, USA. eomeara@u.washington.edu
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
